This is a synthetic peptide designed for use in combination with anti-LPA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains.
Alias Symbols: LP, AK38, APOA, LPA
Protein Interaction Partner: APOH,CANX,CELA1,ELANE,FBLN5,FGB,FN1,LRP2,MMP12,CANX,FGB,FN1,LRP2